Bellerophon Therapeutics, Inc. (BLPH) Social Stream

Featured Post From StockTwits About BLPH

Will post Telegram to join my team once posts complete, follow and don’t miss out! Have a blessed weekend!

$BLPH
Market Price - $4.01
Average Hold - $5.18
Accumulate - Sub $4
Price Target - $7.50
Estimated Time Hold - 1Q
Support - $4.50, $7
Floor - $3.79
Double Down Target - Sub $3.50
Option - N/A
Micro DD - June 18th announced that it has dosed the first patient in the phase III study TOPAZ-1 that will evaluate its humanized IgG1 monoclonal antibody (mAb) candidate, BIIB059, in patients with active systemic lupus erythematosus (SLE). The late-stage study will be conducted across several sites globally and aims to enroll 540 active SLE patients, which will include African-American and Hispanic/Latinx communities.